Tag: investment
-
Business Council Releases Ecosystem Valuation Guide
The World Business Council for Sustainable Development (WBCSD) in Geneva, Switzerland released today its Guide to Corporate Ecosystem Valuation (CEV), to help businesses better understand the benefits and value of ecosystem services like fresh water, food, fiber, and natural hazard protection. The CEV guide can be downloaded free of charge from the WBCSD Web site.…
-
Venture-Backed Exit Value Up, Numbers Down in Q1 2011
The number of exit deals for new companies in the U.S. backed by venture capital (VC) in the first quarter of 2011 dropped, while the total value of the deals increased compared to the same period in 2010. Science-based companies figured prominently in the first-quarter deals involving VC-backed enterprises. Data on exits, where enterprises backed…
-
Merck to Offer Biotech Funding, Incubator in Israel
The global pharmaceutical company Merck in Darmstadt, Germany has opened the Merck Serono Israel Bioincubator Fund, to support Israeli biotech and materials science start up companies. Merck’s chairman Karl-Ludwig Kley announced the initiative yesterday during meetings with officials in Israel. Merck’s incubator program covers pharmaceuticals, life sciences, and high-performance materials. The program will offer start…
-
Finance Friday: 18 March 2011
Here are recent angel and venture finance transactions for science- and engineering-based companies, as reported by Xconomy and Venture Capital Reporter. Biomedical/Life Sciences Advanced Animal Diagnostics in Durham, North Carolina raised $11 million in equity funding with Intersouth Partners and Novartis Venture Funds, the venture capital arm of Novartis Pharmaceuticals, and others. Chronix Biomedical in San Jose,…
-
Finance Friday: 11 March 2011
Here are recent angel and venture finance transactions for science- and engineering-based companies, as reported by Xconomy, Fierce Biotech, and Venture Capital Reporter. Biomedical/Life Sciences Kite Pharma, a start up biotech in Los Angeles, California developing new cancer vaccine therapies, took in $15 million in Series A venture funding, from TPG Capital and other investors.…
-
Monsanto, Biofuels Company to Research Algae Agriculture
Agricultural chemicals maker Monsanto Company in St. Louis, Missouri and Sapphire Energy Inc. in San Diego, California signed a multi-year agreement to use Sapphire’s algae-based research platform for the discovery of genes applicable to agriculture. Sapphire Energy’s current work involves synthetic biology to produce replacement fuels for gasoline, diesel, and jet fuel from algae. Under…
-
Finance Friday: 4 March 2011
Here are recent angel and venture finance transactions for science- and engineering-based companies, as reported by Xconomy and Venture Capital Reporter. Biomedical/Life Sciences Retina Implant AG in Reutlingen, Germany, a medical device company developing sub-retinal implants to help visually impaired people improve their sight, secured $18 million in its second round of equity funding from…
-
EUREKA Network to Fund €33 Million in New European R&D
EUREKA, a network of research officials from 40 countries in Europe and Israel, approved a series of new R&D projects in clean technology and related fields. Meeting in Eilat, Israel, the €33 million ($45.7 million) approved by EUREKA will fund 25 projects in renewable energy, agrofood technology, biotechnology, physical sciences, IT and electronics, and industrial…
-
Venture Fund to Finance Univ. Tech. Start Ups
Osage University Partners in Bala Cynwyd, Pennsylvania says it completed fund raising for its first venture capital fund financing new enterprises that license technology developed in university labs. The company says the fund, called Osage University Partners 1, achieved its goal of raising $100 million. Osage University Partners was founded in 2009 by venture professionals…
-
Finance Friday: 25 February 2011
Here are recent angel and venture finance transactions for science- and engineering-based companies, as reported by Xconomy. Biomedical/Life Sciences CardioFocus in Marlborough, Massachusetts. Attrial fibrilliation devices. $13.6 million in equity financing. CalciMedica in San Diego, California. Biotech with experimental psoriasis candidate. $6 million in venture financing. Acetylon Pharmaceuticals, in Boston, Massacusetts. Drugs to treat cancer…